Revenue Growth The company has shown substantial revenue growth, rising from approximately $10.0M in the prior year to $14.35M in 2024, with another reported $14.4M on July 1, 2024. This indicates growing demand for accreditation services and potential for expanded contract opportunities.

Strategic Partnerships Recent collaboration with the Society of Nuclear Medicine and Molecular Imaging (SNMMI) to co-develop a Radiopharmaceutical Therapy accreditation program signals openness to new program lines and joint ventures, presenting a channel for expanding offerings and cross-sell opportunities.

Technology Stack Adoption of cloud and e-commerce tools (AWS, WordPress, Shopify, Stripe) alongside core financial (Sage Intacct) and marketing/analytics (Crazy Egg, Twitter Ads) infrastructure suggests potential for streamlined sales processes, digital marketing optimization, and scalable client onboarding.

Market Positioning As a specialized accreditation body within hospitals and health care with a mid-size employee base, there is room to position as a cost-effective, niche alternative to larger accrediting entities, enabling targeted outreach to mid-sized clinics and imaging centers seeking compliance upgrades.

Leadership & Growth Longstanding leadership changes and a history of executive appointments (e.g., past president) imply an evolving strategy. This can be leveraged to engage decision-makers about modernization, expanded accreditation programs, and new service lines aligned with evolving regulatory standards.